APA

Klimov A. N., Konstantinov V. O., Lipovetsky B. M., Kuznetsov A. S., Lozovsky V. T., Trufanov V. F., Plavinsky S. L., Gundermann K. J. & Schumacher R. (19961210). "Essential" phospholipids versus nicotinic acid in the treatment of patients with type IIb hyperlipoproteinemia and ischemic heart disease. : Cardiovascular drugs and therapy.

Chicago

Klimov A N, Konstantinov V O, Lipovetsky B M, Kuznetsov A S, Lozovsky V T, Trufanov V F, Plavinsky S L, Gundermann K J and Schumacher R. 19961210. "Essential" phospholipids versus nicotinic acid in the treatment of patients with type IIb hyperlipoproteinemia and ischemic heart disease. : Cardiovascular drugs and therapy.

Harvard

Klimov A. N., Konstantinov V. O., Lipovetsky B. M., Kuznetsov A. S., Lozovsky V. T., Trufanov V. F., Plavinsky S. L., Gundermann K. J. and Schumacher R. (19961210). "Essential" phospholipids versus nicotinic acid in the treatment of patients with type IIb hyperlipoproteinemia and ischemic heart disease. : Cardiovascular drugs and therapy.

MLA

Klimov A N, Konstantinov V O, Lipovetsky B M, Kuznetsov A S, Lozovsky V T, Trufanov V F, Plavinsky S L, Gundermann K J and Schumacher R. "Essential" phospholipids versus nicotinic acid in the treatment of patients with type IIb hyperlipoproteinemia and ischemic heart disease. : Cardiovascular drugs and therapy. 19961210.